Opendata, web and dolomites

EXEDRA SIGNED

EXpansion of the European Joint Programming Initiative on Drug Resistance to Antimicrobials

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "EXEDRA" data sheet

The following table provides information about the project.

Coordinator
VETENSKAPSRADET - SWEDISH RESEARCH COUNCIL 

Organization address
address: VASTRA JARNVAGSGATAN 3
city: STOCKHOLM
postcode: 111 64
website: www.vr.se

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Project website https://www.jpiamr.eu/
 Total cost 2˙231˙438 €
 EC max contribution 2˙149˙202 € (96%)
 Programme 1. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SC1-2016-RTD
 Funding Scheme CSA
 Starting year 2017
 Duration (year-month-day) from 2017-01-01   to  2020-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VETENSKAPSRADET - SWEDISH RESEARCH COUNCIL SE (STOCKHOLM) coordinator 1˙261˙375.00
2    DEUTSCHES ZENTRUM FUER LUFT - UND RAUMFAHRT EV DE (KOELN) participant 272˙452.00
3    ZORGONDERZOEK NEDERLAND ZON NL (DEN HAAG) participant 248˙125.00
4    AGENCE NATIONALE DE LA RECHERCHE FR (PARIS) participant 81˙250.00
5    INSTITUTO DE SALUD CARLOS III ES (MADRID) participant 63˙125.00
6    MINISTERIO DE CIENCIA, TECNOLOGIA E INNOVACION AR (CIUDAD AUTONOMA DE BUENOS AIRES) participant 55˙000.00
7    NARODOWE CENTRUM NAUKI PL (KRAKOW) participant 47˙000.00
8    AGENCIA ESTATAL DE INVESTIGACION ES (MADRID) participant 34˙375.00
9    INSTITUTUL NATIONAL DE CERCETARE-DEZVOLTARE MEDICO-MILITARA CANTACUZINO RO (BUCURESTI) participant 30˙875.00
10    MINISTRY OF HEALTH IL (JERUSALEM) participant 28˙125.00
11    UNITED KINGDOM RESEARCH AND INNOVATION UK (SWINDON) participant 27˙500.00
12    AUTORITATEA NATIONALA PENTRU CERCETARE STIINTIFICA SI INOVARE RO (Bucuresti) participant 0.00
13    BUNDESMINISTERIUM FUER BILDUNG UND FORSCHUNG DE (BONN) participant 0.00
14    CANADIAN INSTITUTES OF HEALTH RESEARCH CA (OTTAWA ONTARIO) participant 0.00
15    MEDICAL RESEARCH COUNCIL UK (SWINDON) participant 0.00
16    Ministerio de Ciencia, Tecnología e Innovación Productiva AR (Buenos Aires) participant 0.00
17    MINISTERIO DE ECONOMIA, INDUSTRIA Y COMPETITIVIDAD ES (MADRID) participant 0.00
18    MINISTERUL CERCETARII SI INOVARII RO (BUCURESTI) participant 0.00
19    SECRETARIA DE GOBIERNO DE CIENCIA, TECNOLOGÍA E INNOVACIÓN PRODUCTIVA AR (BUENOS AIRES) participant 0.00

Map

 Project objective

EXEDRA, an EXpansion of the European Joint Programming Initiative on Drug Resistance to Antimicrobials, will build on, and further support the structure and activities of JPIAMR to address the two major objectives of HCO-04-2016 topic: extending JPIAMR globally and creating a long-term sustainable structure for future expansion and governance which will coordinate national funding and collaborative actions supporting the implementation of the JPIAMR Strategic Research Agenda (SRA).

JPIAMR EXEDRA will be the second Coordinated Support Action (CSA) for this Joint Programming Initiative (JPI) and essentially build on the work of the first CSA (JPIAMR), which ended February 2016. It will provide a strong support structure for the JPIAMR during the forthcoming implementation and expansion phaseby maintaining a continuity between the objectives, tasks and Work Packages of EXEDRA and JPIAMR. Support facilitated by the CSA EXEDRA will ensure that the ethos of joint programming in the area antimicrobial drug resistance becoming embedded within JPIAMR member’s research and innovation policies and programmes.

EXEDRA will have the following work packages: WP1 Management and coordination; WP2 Strategy, governance, and long term sustainability; WP3 Internationalisation and capacity extension; WP4 Alignment with policy and industry; WP5 Research alignment; WP6 Communication, dissemination, and advocacy.

EXEDRA will significantly contribute to the delivery of the JPIAMR SRA combined with the JPI-EC-AMR effort and the experience of the JPIAMR members. EXEDRA (and the JPIAMR) will support transnational cooperation to to pool substantial and long-term research funding and serve to complement other initiatives in the AMR area. It will create momentum with the potential to move the frontiers forward and offer new opportunities for industry, new tools for society, and new evidence-based data for policy makers, which will inspire other necessary initiatives.

 Deliverables

List of deliverables.
JPIAMR communication plan Documents, reports 2020-02-27 11:41:09
Work plan for interaction with industry Documents, reports 2020-02-27 11:41:09
JPIAMR Strategic plan Documents, reports 2020-02-27 11:41:09
Action Plan for countries outside Europe Documents, reports 2020-02-27 11:41:09
Monitoring and evaluation framework Documents, reports 2020-02-27 11:41:09
Action Plan for European countries Documents, reports 2020-02-27 11:41:09
Communications Network Governance Plan Documents, reports 2020-02-27 11:41:09

Take a look to the deliverables list in detail:  detailed list of EXEDRA deliverables.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EXEDRA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EXEDRA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.6.)

GC_1000 (2020)

GROUP CARE FOR THE FIRST 1000 DAYS (GC_1000): If it takes a village to raise a child, group care is the first step

Read More  

SAPHIRE (2018)

Securing Adoption of Personalised Health in REgions

Read More  

EULAC-PerMed (2019)

Widening EU-CELAC policy and research cooperation in Personalised Medicine

Read More